2-Phenyl-1-(2-thioxothiazolidin-3-yl)ethan-1-one, 95%, 1g

[1-(2-Amino-ethyl)-pyrrolidin-3-yl]-carbamic acid tert-butyl ester, 500mg

4,4'-Bis(2,2-diphenylvinyl)-1,1'-biphenyl, 99%, 200mg

1,7-dimethyl-1H-indole-2-carboxylic acid, 95.0%, 250mg

Methyl 2-(3-(aminomethyl)phenyl)acetate hydrochloride, 98%, 250mg

3-tert-Butylcyclobutanone, 98%, 250mg

4-methyl-5-(4-nitrophenyl)-4H-1,2,4-triazole-3-thiol, 5g

Ethyl 4-Iodophenylacetate, 98.0%, 100g

1-(ethylsulfonyl)piperidin-4-amine hydrochloride, 95.0%, 250mg

Mikroliterspritze GASTIGHT® Serie 1700 Point Typ 3, 250 µl, 1725 RNR, 1 Stück

(3Z)-5-bromo-3-[(3-bromo-4,5-dihydroxyphenyl)methylidene]-1H-indol-2-one, 96%, 5mg

5-Methyl-pyridin-3-ylamine, 97.0%, 25g

3,4-Dihydropyrazino[1,2-a]indol-1(2H)-one, 95.0%, 5g